Evidence map›Paper›PMID 37118668›Full record

ArticleBMC cardiovascular disorders2023

Comparison of valvuloplasty and replacement for surgical treatment of tricuspid infective endocarditis.

Linfeng Xie, Xiaodong Chen, Jian He, Sixian Lin, Xingfeng Chen, Qingsong Wu, Ling Chen, Jingxiang Zhuang, Zhihuang Qiu, Liangwan Chen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC cardiovascular disorders, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Long-term outcomes of surgical repair versus replacement for tricuspid valve endocarditis - AInternational journal of cardiology. Heart & vasculature · 2025
    Article
  3. Tricuspid valve repair and replacement for infective endocarditis.Indian journal of thoracic and cardiovascular surgery · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Linfeng Xie *Department of Cardiovascular Surgery, Union Hospital, Fujian Medical University, Fuzhou, Fujian, 350001, P. R. China.
Xiaodong Chen *Department of Cardiovascular Surgery, Union Hospital, Fujian Medical University, Fuzhou, Fujian, 350001, P. R. China.
Jian HeFujian Medical University, Fuzhou, Fujian, 350001, P. R. China.
Sixian LinFujian Medical University, Fuzhou, Fujian, 350001, P. R. China.
Xingfeng ChenDepartment of Cardiovascular Surgery, Union Hospital, Fujian Medical University, Fuzhou, Fujian, 350001, P. R. China.
Qingsong WuDepartment of Cardiovascular Surgery, Union Hospital, Fujian Medical University, Fuzhou, Fujian, 350001, P. R. China.
Ling ChenFujian Medical University, Fuzhou, Fujian, 350001, P. R. China.
Jingxiang ZhuangDepartment of Emergency, Nanjing County Hospital, Zhangzhou, Fujian, P. R. China.
Zhihuang QiuDepartment of Cardiovascular Surgery, Union Hospital, Fujian Medical University, Fuzhou, Fujian, 350001, P. R. China.
Liangwan ChenDepartment of Cardiovascular Surgery, Union Hospital, Fujian Medical University, Fuzhou, Fujian, 350001, P. R. China. chenliangwan@tom.com.
Education Department of Fujian Province · CNFujian Medical University · CNUnion Hospital · CNFujian Provincial Hospital · CNZhangzhou Municipal Hospital of Fujian Province · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOwing to the increase in both intravenous drug injections and intracardiac and vascular interventional treatments among drug users, the incidence of infective endocarditis (IE) involving the tricuspid valve, which sits between the two right heart chambers, has gradually increased. This study aimed to compare the clinical outcomes of different surgical procedures for tricuspid infective endocarditis (TIE).

methodsWe retrospectively analyzed fifty-six patients who underwent tricuspid valve surgery at our hospital from January 2006 to August 2019. All patients were diagnosed with TIE and indicated a need for surgery. Perioperative and follow-up data were collected to summarize and analyze the clinical outcomes of different surgical approaches, including tricuspid valvuloplasty (TVP) and tricuspid valve replacement (TVR) for TIE.

resultsCardiopulmonary bypass (CPB) time, aortic cross-clamp (ACC) time, postoperative mechanical ventilation time, and intensive care unit (ICU) stay time were shorter in the TVP group than in the TVR group. Additionally, the incidence of red blood cell transfusion and postoperative complications was lower in the TVP group than in the TVR group. The postoperative 30-day mortality rates were similar between both the groups. Fifty-two patients were followed up for an average of 5.50 ± 3.79 years. The postoperative 3-, 5-, and 7-year survival rates were 100%, 100%, and 95.5% in the TVP group and 96.7%, 96.7%, and 96.7% in the TVR group, respectively. The 5-year and 10-year reoperation rates were 0% and 0% in the TVP group and 6.7% and 20% in the TVR group, respectively.

conclusionBoth TVR and TVP for TIE significantly improved the functional status of the heart with satisfactory efficacy. TVP was found to be superior to TVR in reducing the need for postoperative blood transfusions, reducing the risk of postoperative complications, and reducing the need for long-term reoperations.

Indexed as

Endocarditis, BacterialHeart Valve Prosthesis ImplantationTricuspid Valve InsufficiencyHumansPostoperative ComplicationsRetrospective StudiesTreatment OutcomeSurgical treatmentTricuspid infective endocarditisTricuspid valve replacementTricuspid valvuloplasty

Identifiers

PMID37118668
PMCPMC10148397
OpenAlexW4367308939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.